Navigation Links
Target for potent first-strike influenza drugs identified
Date:8/2/2012

MEMPHIS, Tenn., Aug. 2, 2012 /PRNewswire-USNewswire/ -- Scientists at St. Jude Children's Research Hospital have reported details of how certain drugs can precisely target and inhibit an enzyme essential for the influenza virus' replication. Since all strains of the virus require the same functioning enzyme, researchers believe their findings will yield drugs that can effectively treat new strains of the virus, which may be resistant to current antiviral treatments.    

When new strains of influenza emerge, it can take many months for a vaccine to be developed. Experts are concerned that the emergence of any highly virulent strains could result in large numbers of people being hospitalized, and if the strain is or becomes resistant to current treatments, the impact could be catastrophic. The researchers' findings may lead to the ability to develop drugs that not only treat influenza but impede the ability of the virus to develop drug resistance. The study appears online in the August 2 issue of PLoS Pathogens.

St. Jude scientists tested drugs aimed at blocking a dual-purpose enzyme complex, called a polymerase, produced by the influenza virus. This polymerase produces copies of the viral genome during replication. It also assembles molecules called messenger RNA (mRNA) that code for viral proteins the virus needs to hijack the cell's machinery to make it produce more virus.

The drugs that investigators tested target an RNA-snipping enzyme called an endonuclease that is a key subunit of the polymerase complex. The endonuclease enables the virus to disguise its messenger RNA so it will be incorporated into the cell's protein-making machinery. This masking consists of snipping apart cellular mRNA, but retaining a segment called a "cap" that the cell's machinery uses to identify its mRNA. The polymerase then attaches this cap to its own mRNA.

"Inhibitors of the polymerase complex would make excellent drug c
'/>"/>

SOURCE St. Jude Children's Research Hospital
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Rheumatoid Arthritis New Major Clinical Target After Mesoblast Obtains Positive Results in Inflammatory Arthritis
2. Multi-Targeted Therapies - New Wave of Combination Therapies in Late Stage Development for Lung Cancer Offer Promise
3. Cancer Cell Article Demonstrates First Definitive Evidence for Targeting of Pol I as New Approach to Cancer Therapy
4. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
5. Whats Next In Vaccines (Malaria, Diabetes, Alzheimers, Allergies and 30 Other Targets in the 2012-2021 Vaccine Pipeline)
6. Van Andel Institute Researchers Find Potential Drug Target For Aggressive Form Of Lymphoma
7. Debiopharm and Ascepion Pharmaceuticals, Inc. Announce an Exclusive License Agreement for the Development and Commercialisation of the Dual-Targeting Kinase Inhibitor, ASP-08126 (Debio 1144), for the Treatment of Oncology Diseases
8. Aperture Health, Inc., Targeting the Strong Growth in the Long Term Disease Management arena
9. ZINO Society Targets Medical Devices, Healthcare IT and Diagnostics
10. Cell Therapeutics to Host Investor and Analyst Meeting to Discuss Targeted Agents in Myelofibrosis and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia on Sunday, June 3, 2012, in Chicago
11. Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 2013  BD (Becton, Dickinson and Company) (NYSE: ... that it will present at the Deutsche Bank 38 th ... at 10:40 a.m. (ET). A live webcast ... website at www.bd.com/investors and will be available for ... BD BD is a leading global medical technology ...
(Date:5/24/2013)... -- Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading ... Dr. Robert Grieve , the Company,s chairman ... , executive vice president and chief financial officer, will present ... held May 30, 2013 in New York City ... The Company,s presentation is scheduled to begin at 1:30 p.m. ...
(Date:5/24/2013)... , May 24, 2013  Sinovac Biotech Ltd. ... of biopharmaceutical products in China ... subsidiary company of Sinovac, obtained the Certificate of ... from the China State and Food Administration (CFDA) ... production plants, and its Changping filing and packaging ...
Breaking Medicine Technology:Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3
... DecisionView Inc., a leading provider of ... life sciences companies, today announced the release of ... flagship solution for patient enrollment planning, tracking and ... into site performance and cost projections, StudyOptimizer 4.3 ...
... 19, 2011 Reportlinker.com announces that ... available in its catalogue: ... http://www.reportlinker.com/p0358494/North-American-External-Defibrillator-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices ... state of the North American external ...
Cached Medicine Technology:DecisionView StudyOptimizer 4.3™ Enhances Market-Leading Enrollment Optimization Solution With Greater Visibility Into Site Performance and Cost Forecasting 2DecisionView StudyOptimizer 4.3™ Enhances Market-Leading Enrollment Optimization Solution With Greater Visibility Into Site Performance and Cost Forecasting 3North American External Defibrillator Market 2North American External Defibrillator Market 3North American External Defibrillator Market 4North American External Defibrillator Market 5North American External Defibrillator Market 6
(Date:5/25/2013)... 25 (HealthDay News) -- Animals make great companions for senior ... in the car are far more likely to crash than ... The new study included 2,000 licensed drivers aged 70 ... asked how often they drove with their pet in the ... the crash risk was twice as high as among those ...
(Date:5/25/2013)... Studies from Johns Hopkins University reveal a direct ... their inability to get adequate sleep. These same studies ... relieve many symptoms. , Johns Hopkins University School ... significantly associated with overall weight loss, especially belly fat. ... 6th, 2012, researchers monitored 77 participants who were diabetic ...
(Date:5/25/2013)... May 25, 2013 On May 20, 2013 ... do not wish to discuss or plan for their eventual ... FuneralFinancials.com released a Must-Do List to help people ... Financials recommends, “Creating a personal fact sheet.” , While not ... financial information and personal data. It may include a ...
(Date:5/25/2013)... By working diligently for months on ... of the 2012 Lamborghini Aventador into their well-built fitments ... in the list of vehicles lined by SizeItUp for ... set to thrill automobile lovers in the year 2013. ... looks, the 2012 Lamborghini Aventador comes with extraordinarily spacious ...
(Date:5/25/2013)... Many orthodontists have thought about moving their office ... is. Most people would naturally assume that the ... cloud service and support would own and maintain all ... they'd be wrong. Cloud providers lease space in ... that houses servers and related equipment to run cloud ...
Breaking Medicine News(10 mins):Health News:Seniors More Likely to Crash When Driving With Pet: Study 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2
... School of Public Health (HSPH) have found that children ... laws promoting smoke-free public places have significantly lower levels ... those living in counties with no smoke-free laws. ... with smoke-free laws had 39% lower prevalence of cotinine ...
... June 5 Patients undergoing treatment for melanoma that ... chemotherapy delivered directly into the liver,s blood vessels, according ... and Delcath Systems Inc., and led by James F. ... School of Medicine, and surgical oncologist with UPMC Cancer ...
... Studies show combo chemotherapy, new drug prolonged lives of ... News) -- Researchers report they prolonged survival for some ... the median survival is currently only about six months. ... called crizotinib shrank tumors in the majority of lung ...
... millions in hopes of protection against cancer and a host ... in reducing a patient,s risk of developing lung cancer - ... of an international Phase III clinical trial. Results from ... were presented today at the American Society of Clinical Oncology ...
... ... J. Brueck MD FACS, Fort Myers cosmetic surgeon, has applied stem cell therapy ... exist in a person’s fat. It can be harvested and spun down. It ... PRP is the result of the blood being spun down to create a ...
... ... the Savory Institute and the Africa Centre for Holistic Management are winning awards for their ... rivers back to life, increase food production and security and store carbon in ever deeper ... (PRWEB) ...
Cached Medicine News:Health News:Smoke-free air laws effective at protecting children from secondhand smoke 2Health News:New treatment method safe, effective for advanced melanoma patients 2Health News:Researchers Report Treatment Headway Against Lung Cancer 2Health News:Researchers Report Treatment Headway Against Lung Cancer 3Health News:Selenium shows no benefit in prevention of lung cancer 2Health News:Selenium shows no benefit in prevention of lung cancer 3Health News:Ft Myers Plastic Surgeon, Dr. Robert J. Brueck MD, Performs Facial Rejuvenation Using Innovative Stem Cell Therapy 2Health News:Ft Myers Plastic Surgeon, Dr. Robert J. Brueck MD, Performs Facial Rejuvenation Using Innovative Stem Cell Therapy 3Health News:Holistic Management and Allan Savory Win the 2010 Buckminster Fuller Award for Turning Deserts into Thriving Grasslands and Combating Climate Change. 2
... Many special order products are offered as ... long lengths. The modular instruments may be ... options such as ratchets, insulation and flush ... Mediflex stock. Customer specifications may affect delivery ...
... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
... a layered design unique in the industry. ... prevent stray electrosurgical burns along the shaft ... or capacitive coupling; a well-documented patient safety ... AEM Instruments provides a neutral return path ...
... The 5mm AEM Laparoscopic Instruments incorporate a ... Instruments are shielded and monitored to prevent ... the instrument caused by insulation failure or ... The protective shield built into all AEM ...
Medicine Products: